PACS (NYSE) Form 144: 45,000 shares listed with J.P. Morgan
Rhea-AI Filing Summary
PACS submitted a Form 144 notice listing proposed sales of Common Stock through J.P. Morgan Securities LLC. The filing lists a proposed sale quantity of 45,000 shares, a beneficially held figure of 1,748,250 shares, and a total share count of 158,272,376 with an effective date of 06/25/2026. The notice also identifies RSU vesting-related shares of 31,616 (04/15/2026) and 13,384 (04/15/2025) shown as compensation.
Positive
- None.
Negative
- None.
Insights
Form 144 filed for proposed resale of common shares via J.P. Morgan.
The filing lists specific share counts: 45,000 shares proposed for sale, 1,748,250 shares listed in a holding column, and a total share figure of 158,272,376 dated 06/25/2026. It also records RSU vesting entries of 31,616 and 13,384 tied to 04/15/2026 and 04/15/2025, respectively.
These entries are administrative notices under resale rules; actual transaction timing, method, and proceeds are not shown in the excerpt. Subsequent trade execution and broker reports would confirm whether sales occurred and their cash treatment.
Key Figures
Key Terms
Form 144 regulatory
RSU Vesting financial
J.P. Morgan Securities LLC other
FAQ
What does PACS's Form 144 filing mean?
Who is the broker-dealer handling the reported sale for PACS?
Does the Form 144 show completed sales or proceeds for PACS?
AI-generated analysis. How Rhea-AI works. Not financial advice.